The FDA approves a new non-opioid pain pill, Journavx, to treat acute pain in adults. It's a first-generation non-addictive pain medicine.

According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ...

SEVEN NEWS. HEY! WELCOME BACK. NEW PAIN MEDICATION HAS BEEN APPROVED BY THE FDA. IT SUPPOSEDLY NON-ADDICTIVE DARLENE MELENDEZ SPOKE WITH. UNM HEALTH EXPERT DOCTOR ASH ON HOW THIS WORKS.

Doerring, M.D., former FDA medical officer in the division of psychiatry and the founder and CEO of TaperClinic, he shares ...

Optum Rx, a pharmacy benefit manager owned by one of the country’s largest insurance companies, UnitedHealth Group, has added a new ... to cover non-opioid pain medications.

Register for free now. This marked the first approval of a new class of pain medication in more than 20 years, offering an alternative to traditional opioid treatments. According to the Formulary ...

Several medications now calm painful inflammation in the intestines. Diets free of ultraprocessed foods also help ...

The first daily pill for treating endometriosis symptoms has been approved for use on the NHS in England and Wales - but only ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. The new development is ...